Shrinivas Bishu - Concepedia

Author

Shrinivas Bishu

Also Known As

Bishu S, J. Schmitz, Josh Korzenik, N Kamada, S Bishu, S. Bishu, S. R. Bishu, Shreenath R Bishu, Shrinivas Bishu, Srinivas Bishu

165

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

University of Michigan Michigan Medicine National Institute of Mental Health VA Center for Clinical Management Research National Institutes of Health

About

Shrinivas Bishu is an author at University of Michigan specializing in medicine, gastroenterology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	18	1.8K
2	Health Sciences	3	3	136
3	Social Sciences	2	2	88
4	Language Studies	1	1	21
5	Public Health	1	1	150

Shrinivas Bishu

Publications

Citations

H-Index

Page 1

	Year	Citations
The Intermucosal Connection between the Mouth and Gut in Commensal Pathobiont-Driven Colitis Sho Kitamoto, Hiroko Nagao‐Kitamoto, Yizu Jiao, Cell Commensal Pathobiont-driven ColitisMucosal ImmunologyGastroenterologyDigestive TractIntestinal Microbiota	2020	610
Performance of a Deep Learning Model vs Human Reviewers in Grading Endoscopic Disease Severity of Patients With Ulcerative Colitis Ryan W. Stidham, Wenshuo Liu, Shrinivas Bishu, JAMA Network Open	2019	260
Oral-resident natural Th17 cells and γδ T cells control opportunistic <i>Candida albicans</i> infections Heather R. Conti, Alanna Peterson, Lucas Brane, The Journal of Experimental Medicine	2014	252
Dietary l-serine confers a competitive fitness advantage to Enterobacteriaceae in the inflamed gut Sho Kitamoto, Christopher J. Alteri, Michael Rodrigues, Nature Microbiology BiologyNutritionDysbiosisInflamed GutGut Microbiology	2019	150
Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control Study Jeffrey Berinstein, Jessica L. Sheehan, Michael Dias, Clinical Gastroenterology and Hepatology Retrospective Case-control StudyGastroenterologyTherapeutic ControversyBiologic-experienced Hospitalized PatientsUlcerative Colitis	2021	121
Fully automated endoscopic disease activity assessment in ulcerative colitis Heming Yao, Kayvan Najarian, Jonathan Gryak, Gastrointestinal Endoscopy GastroenterologyDiagnosisGi TechniqueUlcerative ColitisMedicine	2020	110
Efficacy of Induction Therapy With High-Intensity Tofacitinib in 4 Patients With Acute Severe Ulcerative Colitis Jeffrey Berinstein, Calen A. Steiner, Randolph E. Regal, Clinical Gastroenterology and Hepatology InflammationHigh-intensity TofacitinibGastroenterologyClinical GastroenterologyUlcerative Colitis	2018	104
A potential pathogenic association between periodontal disease and Crohn’s disease Jin Imai, Hitoshi Ichikawa, Sho Kitamoto, JCI Insight InflammationChronic Inflammatory DiseasesPeriodontal DiseaseDysbiosisOral Conditions	2021	87
Efficacy and Outcome of Tofacitinib in Immune checkpoint Inhibitor Colitis Shrinivas Bishu, Joanna Melia, William H. Sharfman, Gastroenterology InflammationAnti-inflammatoryAutoimmune DiseaseImmunologyPathology	2020	80
Effects of Anti–Helicobacter pylori Therapy on Incidence of Autoimmune Diseases, Including Inflammatory Bowel Diseases Kun‐Der Lin, Guei-Fen Chiu, Akbar K. Waljee, Clinical Gastroenterology and Hepatology InflammationAutoimmune DiseaseImmunologyGastroenterologyAutoimmunity	2018	74

Page 1